Kura Oncology, Inc. (KURA) › Operating IncomeKura Oncology, Inc. (KURA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$20.5K2011: -$23.4K2012: -$22.3K2013: -$22.7K2022: -$139.87M2023: -$165.80M2024: -$193.19M2025: -$303.63M-$303.63M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$303.63M-57.2%2024-$193.19M-16.5%2023-$165.80M-18.5%2022-$139.87M—2013-$22.7K-1.8%2012-$22.3K+4.7%2011-$23.4K-14.3%2010-$20.5K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share